Regeneron Pharmaceuticals, Inc.REGNNASDAQ
Loading
Income Before Tax Over TimeStrong
Percentile Rank93
3Y CAGR+2.5%
5Y CAGR+6.5%
Year-over-Year Change
Pre-tax earnings
3Y CAGR
+2.5%/yr
vs +17.4%/yr prior
5Y CAGR
+6.5%/yr
Recent deceleration
Acceleration
-15.0pp
Decelerating
Percentile
P93
Near historical high
vs 5Y Ago
1.4x
Solid growth
Streak
2 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $5.23B | +9.4% |
| 2024 | $4.78B | +13.8% |
| 2023 | $4.20B | -13.6% |
| 2022 | $4.86B | -47.9% |
| 2021 | $9.33B | +144.7% |
| 2020 | $3.81B | +56.9% |
| 2019 | $2.43B | -4.9% |
| 2018 | $2.55B | +22.9% |
| 2017 | $2.08B | +56.3% |
| 2016 | $1.33B | - |